BPBT
KYTH

Boston Private Bank & Trust’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Boston Private Bank & Trust’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$2K Hold
30
– – ﹤0.01% 991
2014
Q4 		$1K Buy
+30
New +$1.05K ﹤0.01% 1133

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Private Bank & Trust's KYTH Position: Q1 2015 in Review

Boston Private Bank & Trust held its KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) position steady in Q1 2015 at 30 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Boston Private Bank & Trust first reported a position in KYTH in Q4 2014 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold KYTH as of Q1 2015.

  • Boston Private Bank & Trust held 30 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $2K as of Q1 2015.
  • Boston Private Bank & Trust left its KYTHERA BIOPHARMACEUTICALS, INC COM share count unchanged in Q1 2015.
  • KYTHERA BIOPHARMACEUTICALS, INC COM made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #991 holding.
  • Boston Private Bank & Trust first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2014 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.